Dow Down0.17% Nasdaq Down0.28%

Northwest Biotherapeutics, Inc. (NWBO)

-NasdaqCM
5.03 Down 0.18(3.45%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue -   -   -   400  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   400  
Operating Expenses
Research Development21,549  19,986  11,121  12,794  
Selling General and Administrative3,877  3,693  3,549  3,055  
Non Recurring -   -   -   -  
Others3  3  3  3  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (25,429) (23,682) (14,673) (15,452)
Income from Continuing Operations
Total Other Income/Expenses Net(403)(22,237)(2,082)(7,392)
Earnings Before Interest And Taxes(25,832)(45,919)(16,755)(22,844)
Interest Expense33  122  136  66  
Income Before Tax(25,865)(46,041)(16,891)(22,910)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(25,865)(46,041)(16,891)(22,910)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (25,865) (46,041) (16,891) (22,910)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (25,865) (46,041) (16,891) (22,910)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.